Silence Therapeutics (SLN) Q4 2025 Earnings

6NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.07
-0.04
-0.01
0.02

Details

Expected EPS
-0.0627714516
Actual EPS
-0.0512960162
Surprise EPS
0.01
Surprise Percent
+18.28%

Description

Silence Therapeutics (SLN) has reported earnings of -0.0512960162 per share for Q4 2025.

0 Comments

Share your thoughts